Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1429309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Thayza M I L Santos und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Pesquisa em Virologia, Departamento de Doenças Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto, São José do…. Hauptthemen laut MEDLINE: Dengue, COVID-19, SARS-CoV-2, Antibodies, Viral. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Since its emergence in 2019, coronavirus disease (COVID-19) has spread worldwide and consumed public health resources. However, the world still has to address the burdens of other infectious diseases that continue to thrive. Countries in the tropics and neotropics, including Brazil, are affected by annual, cyclic dengue epidemics. Little is known about the impact of subsequent infections between DENV and SARS-CoV-2. Our study was performed on 400 serum samples collected from laboratory-confirmed COVID-19 patients between January and June 2021, months historically known for DENV outbreaks in Brazil. The samples were tested by serology and molecular assays for the presence of DENV and other arboviruses. While no DENV PCR results were detected, 6% were DENV IgM-positive, and 0.25% were DENV NS1-positive according to ELISA. IgM antibodies were isolated by chromatography, and 62.5% of the samples were positive for neutralizing antibodies (FRNT 80 ) against DENV IgM, suggesting a recent infection. We also observed increased IL-10, TNF-α, and IL-1β levels in patients with overlapping SARS-CoV-2/DENV infections. Intriguingly, diabetes was the only relevant comorbidity (p=0.046). High rates of hospitalization (94.9%) and mortality (50%) were found, with a significant increase in invasive mechanical ventilatory support (86.96%) in SARS-CoV-2/DENV- infected patients, suggesting an impact on patient clinical outcomes. When analyzing previous exposure to DENV, secondary dengue patients infected with SARS-CoV-2 more frequently presented with dyspnea and respiratory distress, longer hospital and intensive care unit (ICU) stays (4 and 20.29 days, respectively) and a higher mortality rate (60%). However, a greater proportion of patients with primary DENV infection had fever and cough than patients with secondary dengue (87.50% vs. 33.33%, p=0.027 for fever). Our data demonstrate that differentiating between the two diseases is a great concern for tropical countries and should be explored to improve patient management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Pesquisa em Virologia, Departamento de Doenças Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil.
- Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.
- Prefeitura de São José do Rio Preto, Vigilância Epidemiológica, São José do Rio Preto, Brazil.
- Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Laboratorio de Virologia Basica e Aplicada, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Center for Vector-Borne and Zoonotic Diseases, University of Texas Medical Branch, Galveston, TX, United States.
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Santos, T. M. I. L., Versiani, A. F., Campos, G. R. F., Moraes, M. M., Parra, M. C. P., Mistrao, N. F. B., Negri, A. F., Bagno, F. F., Galves, M. G., Moreno, C. M., Da Fonseca, F. G., Estofolete, C. F., Vasilakis, N., & Nogueira, M. L. (2024). Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1429309
Vancouver
Santos TMIL, Versiani AF, Campos GRF, Moraes MM, Parra MCP, Mistrao NFB, et al. Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1429309
BibTeX
@article{Santos2024,
author = {Santos, Thayza M I L and Versiani, Alice F and Campos, Guilherme R F and Moraes, Marilia M and Parra, Maisa C P and Mistrao, Natalia F B and Negri, Andreia F and Bagno, Flavia F and Galves, Marina G and Moreno, Camila M and Da Fonseca, Flavio G and Estofolete, Cassia F and Vasilakis, Nikos and Nogueira, Mauricio L},
title = {Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1429309}
}
EUVIMED